Updates on the Evolving Role of Multidisciplinary Care Teams for the Management of Patients with Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy: Earlier Detection and Comprehensive Care
Post-Test/Evaluation

Exit Survey

Questions marked with a * are required

19%

Contact Information

First Name

Last Name

Email Address

Credentials/Degree (MD, DO, RN, etc.)

Date of Participation

A 4-year-old boy presents to his pediatrician for an annual visit. The parents state that he learned to walk at around 2 years of age, but has had continued difficulty, particularly with running, jumping, and negotiating stairs. They are also concerned about his coordination, as he falls frequently. The mother states that she is aware of one cousin who had a child with DMD. Which of the following tests would you order that, if elevated, would be a good indicator to test further for DMD in this patient?

Creatine kinase

White blood cells

Amylase

Erythrocyte sedimentation rate

Which of the following is true regarding healthcare disparities in the management of patients with DMD?

Most races are represented equally in clinical trials

DMD is generally identified at similar age (~3 years of age), regardless of race

Average time to diagnosis for all patients with DMD is 2 years; for Blacks, it is faster, at 1.4 years

Corticosteroids are offered and started at older age in Hispanic and non-Hispanic Blacks, compared to Whites